An experimental obesity drug called retatrutide that targets GLP-1 and two other hormones helped people lose nearly one-third of their starting body weight, on average, in a late-stage clinical trial
Is it safe to start a GLP1 receptor agonist (e.g., exenatide, liraglutide) in a patient with thyroid nodules?
S.MartoranaF.et al (2019)
Wu Q, Xia Y, Dai K, Bai P, Kwan KKL, Guo MSS
Noda Y, Miyoshi T, Oe H, Ohno Y, Nakamura K, Toh N, Kohno K, Morita H, Kusano K, Ito H (2013) Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report
We understand the importance of consistent quality and reliable delivery, which is why we work with trusted manufacturers to provide products that meet strict industry standards